The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I trial of BMS-986253, an anti-IL-8 monoclonal antibody, in patients with metastatic or unresectable solid tumors.
 
Julie Marie Collins
No Relationships to Disclose
 
Christopher Ryan Heery
Employment - Bavarian Nordic
Leadership - Bavarian Nordic
Stock and Other Ownership Interests - Bavarian Nordic
Honoraria - MPM Capital
Consulting or Advisory Role - MPM Capital
Travel, Accommodations, Expenses - Bavarian Nordic; MPM Capital
 
Renee Nicole Donahue
No Relationships to Disclose
 
Claudia Palena
Employment - MacroGenics (I)
Leadership - Macrogenics (I)
Stock and Other Ownership Interests - Macrogenics (I)
Research Funding - Macrogenics (I)
Patents, Royalties, Other Intellectual Property - Macrogenics-Patents (I)
 
Ravi Amrit Madan
Speakers' Bureau - Boehringer Ingelheim (I); Janssen (I); Pfizer (I)
 
Julius Strauss
Patents, Royalties, Other Intellectual Property - I am listed as an inventor on an NIH patent. (Inst)
 
Margaret Elena Gatti-Mays
No Relationships to Disclose
 
Jeffrey Schlom
Research Funding - Bavarian Nordic (Inst)
Patents, Royalties, Other Intellectual Property - If applicable; If applicable (Inst)
 
James L. Gulley
Research Funding - Astellas Medivation (Inst); Bavarian Nordic (Inst); EMD Serono (Inst); NantBioScience (Inst); Pfizer (Inst)
 
Marijo Bilusic
Consulting or Advisory Role - Astellas Pharma; Bayer; Dendreon
Research Funding - Ambry Genetics (Inst); Bavarian Nordic (Inst); Johnson & Johnson (Inst); Sotio (Inst)